Stonebridge Financial Group LLC acquired a new position in shares of CVS Health Co. (NYSE:CVS – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 628 shares of the pharmacy operator’s stock, valued at approximately $28,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health during the third quarter worth approximately $25,000. Ridgewood Investments LLC grew its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health during the 3rd quarter worth $31,000. Finally, Reston Wealth Management LLC purchased a new position in CVS Health during the 3rd quarter worth $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on CVS. Leerink Partners upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and increased their target price for the stock from $55.00 to $75.00 in a research note on Thursday. Barclays boosted their target price on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday. Leerink Partnrs upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. Evercore ISI raised their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. Finally, Piper Sandler dropped their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $70.28.
CVS Health Trading Down 1.0 %
Shares of CVS opened at $65.71 on Friday. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm has a 50 day simple moving average of $50.90 and a 200-day simple moving average of $56.01. The stock has a market cap of $82.68 billion, a price-to-earnings ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Equities analysts forecast that CVS Health Co. will post 5.14 EPS for the current fiscal year.
CVS Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 67.51%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
- Five stocks we like better than CVS Health
- ESG Stocks, What Investors Should Know
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Differences Between Momentum Investing and Long Term Investing
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What is the Shanghai Stock Exchange Composite Index?
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.